Would you restart endocrine therapy for a patient with new contralateral LCIS diagnosed 2 years following completion of AI therapy for stage 1A HR+ IDC?

Topics: Breast Cancer • Medical Oncology • Cancer Prevention • Breast Cancer, Non-metastatic

Would you restart hormonal therapy in a patient with a new diagnosis of LCIS 2 years after they have completed 5 yrs of AI for stage 1A IDC in the other breast

Answer from: Medical Oncologist at Academic Institution

The primary prevention trials (NSABP-1, STAR, etc) largely excluded women with a prior history of cancer and certainly did not include those who'd had 5 previous yrs of endocrine therapy. While I think you could discuss an additional 5 yrs of endocrine therapy, an additional 5 yrs of AI (e.g. 5-10 t...

Comments

Medical Oncologist at New York Methodist Hosp
Would you consider raloxifene if osteoporosis on b...

Medical Oncologist at Mayo Clinic Rochester
@David Dosik, we could also consider raloxifene, a...

Related Questions